Overview

Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study

Status:
Unknown status

Trial end date:
2020-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether isotretinoin is helpful in treating patients with an adverse cutaneous drug eruption known as toxic epidermal necrolysis (TEN).

Phase:

N/A

Details

Lead Sponsor:

Massachusetts General Hospital

Treatments:

Isotretinoin